Cargando…

Immunopharmacological Approach of Carvedilol in Chronic Chagas Heart Disease

Detalles Bibliográficos
Autores principales:	Miranda, Carla Paixão, Botoni, Fernando Antônio, Rocha, Manoel Otávio da Costa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia 2014
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206367/ https://www.ncbi.nlm.nih.gov/pubmed/25352510 http://dx.doi.org/10.5935/abc.20140153

Ejemplares similares

The metabogenic role of iron in chronic chagasic cardiac failure
por: Miranda, Carla Paixão, et al.
Publicado: (2015)

Níveis Séricos do BDNF na Proteção Cardiovascular e em Resposta ao Exercício
por: Miranda, Carla Paixão, et al.
Publicado: (2021)

Analysis of Iron Metabolism in Chronic Chagasic Cardiomyopathy
por: Miranda, Carla Paixão, et al.
Publicado: (2019)

Uso de Estatinas Melhora a Proteção Cardiometabólica Promovida pelo Treinamento Físico em Ambiente Aquático: Um Estudo Clínico Randomizado
por: Miranda, Carla Paixão, et al.
Publicado: (2022)

Intestinal permeability evaluation in patients with chronic Chagas heart failure
por: Rodrigues, Angela Braga, et al.
Publicado: (2023)

Biomakers in Chronic Chagas Cardiomyopathy
por: Rodrigues, Angela Braga, et al.
Publicado: (2022)

Treatment of Chagas Cardiomyopathy
por: Botoni, Fernando A., et al.
Publicado: (2013)

Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid
por: Unal, Gokhan, et al.
Publicado: (2020)

Carvedilol Enhances the Antioxidant Effect of Vitamins E and C in Chronic Chagas Heart Disease
por: Budni, Patrícia, et al.
Publicado: (2013)

Heart Rate Variability and Chagas Heart Disease
por: Almeida-Santos, Marcos Antonio, et al.
Publicado: (2015)

Textbook of immunopharmacology /
Publicado: (1984)

Immunopharmacological Activities of Luteolin in Chronic Diseases
por: Huang, Lei, et al.
Publicado: (2023)

Immunopharmacology of allergic diseases /
Publicado: (1996)

Section 4: Immunopharmacology
Publicado: (2017)

Immunopharmacology of Post-Myocardial Infarction and Heart Failure Medications
por: Panahi, Mona, et al.
Publicado: (2018)

Effects of Exercise Training on Heart Rate Variability in Chagas Heart Disease
por: Nascimento, Bruno Ramos, et al.
Publicado: (2014)

Immunopharmacology of ulipristal as an emergency contraceptive
por: Miech, Ralph P
Publicado: (2011)

Immunobiology and immunopharmacology of bacterial endotoxins
por: Szentivanyi, Andor, et al.
Publicado: (1986)

Heart Rate Recovery in Asymptomatic Patients with Chagas Disease
por: de Alencar, Maria Clara Noman, et al.
Publicado: (2014)

Functional antibodies against G-protein coupled receptors in Beagle dogs infected with two different strains of Trypanosoma cruzi
por: Wallukat, Gerd, et al.
Publicado: (2022)

Galectin-3 and fibrosis intensity in Chronic Chagas Cardiomyopathy: a systematic review
por: Chaves, Ana Thereza, et al.
Publicado: (2022)

Six-minute walk test and incremental shuttle walk test in the evaluation of functional capacity in Chagas heart disease
por: Costa, Henrique Silveira, et al.
Publicado: (2018)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

Reply: Sacubitril/valsartan for Chagas' heart disease heart failure?
por: Bocchi, Edimar Alcides, et al.
Publicado: (2018)

Cardiac Medications Can Influence the Exercise Prescription in Chagas Heart Disease
por: Cunha, Raphael Martins, et al.
Publicado: (2015)

Editorial: Anti-inflammatory immunopharmacology in the prevention and treatment of major chronic diseases
por: Zhang, Qiuwang, et al.
Publicado: (2023)

Updated Considerations for the Immunopharmacological Aspects of the “Talented mRNA Vaccines”
por: Perrotta, Cristiana, et al.
Publicado: (2023)

Assessment of Functional Capacity in Chagas Heart Disease by Incremental Shuttle Walk Test and its Relation to Quality-of-Life
por: Costa, Henrique Silveira, et al.
Publicado: (2014)

Immunopharmacology and Quantitative Analysis of Tyrosine Kinase Signaling
por: Brian, Ben F., et al.
Publicado: (2020)

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology
por: Harding, Simon D., et al.
Publicado: (2020)

Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives
por: Chigbu, DeGaulle I., et al.
Publicado: (2021)

Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al.
por: Ramires, Felix J.A., et al.
Publicado: (2018)

Carvedilol in the treatment of elderly patients with chronic heart failure
por: Witte, Klaus KA, et al.
Publicado: (2008)

Fragmented QRS and Chagas' disease
por: Baranchuk, Adrian
Publicado: (2014)

Chagas Disease in Ancient Hunter-Gatherer Population, Brazil
por: Lima, Valdirene S., et al.
Publicado: (2008)

Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2
por: Skayem, Charbel, et al.
Publicado: (2020)

Physician Awareness of Chagas Disease, USA
por: Stimpert, Kelly K., et al.
Publicado: (2010)

Immunopharmacology and the regulation of leukocyte function. Immunology series—Vol 19
por: Kimber, I.
Publicado: (1983)

Kdo(2)-lipid A: structural diversity and impact on immunopharmacology
por: Wang, Xiaoyuan, et al.
Publicado: (2015)

Safety immunopharmacology: Evaluation of the adverse potential of pharmaceuticals on the immune system
por: Descotes, Jacques
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1bvcc3fb37h4k9unt3vfj8b9h9